ArticleFrontiers in oncology2023

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.

Cheng Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.